Brain cancer patient treated with off-label drug frets over costs when insurance coverage stops in April 2023

1 month ago 250

Senior Health Correspondent

SINGAPORE - Mr Zhang Chang Hua is 42 years old and works in regional customer service for a multinational company. He and his wife, a nurse, have two sons in secondary school. He also has brain cancer.

His cancer has been under control for the past year with a drug used off-label - meaning the drug has not been approved for this particular type of cancer. With this drug, his oncologist says he has many good years ahead of him.

Already a subscriber? Log in

ST One Digital

 $9.90/month

No contract

ST app access on 1 mobile device

Unlock these benefits

  • All subscriber-only content on ST app and straitstimes.com

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Read Entire Article